Suramin protects from cisplatin-induced acute kidney injury

Cisplatin, a commonly used cancer chemotherapeutic, has a dose-limiting side effect of nephrotoxicity. Approximately 30% of patients administered cisplatin suffer from kidney injury, and there are limited treatment options for the treatment of cisplatin-induced kidney injury. Suramin, which is Feder...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Physiol Renal Physiol
Main Authors: Dupre, Tess V., Doll, Mark A., Shah, Parag P., Sharp, Cierra N., Kiefer, Alex, Scherzer, Michael T., Saurabh, Kumar, Saforo, Doug, Siow, Deanna, Casson, Lavona, Arteel, Gavin E., Jenson, Alfred Bennett, Megyesi, Judit, Schnellmann, Rick G., Beverly, Levi J., Siskind, Leah J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877945/
https://ncbi.nlm.nih.gov/pubmed/26661653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00433.2015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados